Column Group LLC Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$82.8M

Holdings

5

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
SRZNSurrozen, Inc.
1,851,350$41.8M50.54%
2
ORICORIC Pharmaceuticals Inc.
3,540,777$29.0M34.98%
3
TNYATenaya Therapeutics, Inc.
9,400,290$6.7M8.08%
4
RAPTEURRAPT Therapeutics Inc
156,270$5.3M6.39%
5
RVMDRevolution Medicines Inc
46$3K0.00%